BRCA2 and MRE11 Mutations in Gastrointestinal Cancers
Author Information
Author(s): van der Heijden Michiel S, Brody Jonathan R, Elghalbzouri-Maghrani Elhaam, Zdzienicka Malgorzata Z, Kern Scott E
Primary Institution: The Johns Hopkins University School of Medicine
Hypothesis
Does tumorigenesis select for or against mutations of the DNA repair-associated genes BRCA2 and MRE11?
Conclusion
The data suggest that there is no selective pressure favoring the loss of BRCA2 and MRE11 function in MSI tumors.
Supporting Evidence
- Heterozygous truncating mutations in BRCA2 were found in 47% of the patients studied.
- Functional testing showed no defect in RAD51 focus formation in mutated cell lines.
- Statistical analysis did not support selective pressure favoring biallelic mutations in BRCA2 and MRE11.
Takeaway
This study looked at cancer cells and found that mutations in certain genes didn't help the cancer grow, which is surprising because many thought they would.
Methodology
Whole gene sequencing of BRCA2 and analysis of MRE11 mutations in gastrointestinal MSI cancer cell lines.
Limitations
The study was limited by the small number of MSI cancer cell lines available for analysis.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website